Literature DB >> 10525502

Warfarin in atrial fibrillation: underused in the elderly, often inappropriately used in the young.

R G Hart.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10525502      PMCID： PMC1760763          DOI： 10.1136/hrt.82.5.539

Source DB:  PubMed          Journal:  Heart        ISSN： 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  10 in total

1.  Valsartan in acute myocardial infarction trial.

Authors:  Ileana L Piña
Journal:  Curr Cardiol Rep       Date:  2004-05       Impact factor: 2.931

2.  Rehospitalization and survival for stroke patients in managed care and traditional Medicare plans.

Authors:  Maureen A Smith; Jennifer R Frytak; Jinn-Ing Liou; Michael D Finch
Journal:  Med Care       Date:  2005-09       Impact factor: 2.983

3.  Cost effectiveness of rivaroxaban for stroke prevention in German patients with atrial fibrillation.

Authors:  Alexander Mensch; Stephanie Stock; Björn Stollenwerk; Dirk Müller
Journal:  Pharmacoeconomics       Date:  2015-03       Impact factor: 4.981

4.  Atrial fibrillation: will new drugs and patient choice improve anticoagulation outcomes?

Authors:  R Fuller; N J Dudley
Journal:  Heart       Date:  2005-04       Impact factor: 5.994

Review 5.  Prevention of cardiovascular events in elderly people.

Authors:  Wafik Farah Andrawes; Caroline Bussy; Joël Belmin
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

Review 6.  Risk factor management to prevent first stroke.

Authors:  Tatjana Rundek; Ralph L Sacco
Journal:  Neurol Clin       Date:  2008-11       Impact factor: 3.806

7.  Comparison of cost-effectiveness of anticoagulation with dabigatran, rivaroxaban and apixaban in patients with non-valvular atrial fibrillation across countries.

Authors:  Martin Krejczy; Job Harenberg; Svetlana Marx; Konrad Obermann; Lutz Frölich; Martin Wehling
Journal:  J Thromb Thrombolysis       Date:  2014-05       Impact factor: 2.300

8.  Left Atrial Appendage Closure in Atrial Fibrillation: A World without Anticoagulation?

Authors:  Tahmeed Contractor; Atul Khasnis
Journal:  Cardiol Res Pract       Date:  2011-03-30       Impact factor: 1.866

9.  Atrial fibrillation in a primary care practice: prevalence and management.

Authors:  Lance Ceresne; Ross E Upshur
Journal:  BMC Fam Pract       Date:  2002-05-24       Impact factor: 2.497

10.  Implementing hospital guidelines improves warfarin use in non-valvular atrial fibrillation: a before-after study.

Authors:  Simona Bo; Susanna Valpreda; Luca Scaglione; Daniela Boscolo; Marina Piobbici; Mario Bo; Giovannino Ciccone
Journal:  BMC Public Health       Date:  2007-08-10       Impact factor: 3.295
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.